Safety and Efficacy of Inhaled Treprostinil in Patients With PAH

NCT01557647 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: Inhaled treprostinil
DRUG: Placebo

Sponsor

United Therapeutics